COST COMPARISON OF ORCHIECTOMY AND LEUPROLIDE IN METASTATIC PROSTATE CANCER
- 1 December 1998
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 160 (6) , 2446-2449
- https://doi.org/10.1016/s0022-5347(01)62207-9
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- PROSTATE-SPECIFIC ANTIGEN AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMYUrologic Clinics of North America, 1997
- Orchidectomy or LHRH-Analogue? Which Do the Patients Prefer and What Treatment Would Norwegian Urologists Prefer if They Had Advanced Cancer of the Prostate?Scandinavian Journal of Urology and Nephrology, 1991
- Combination Studies with LeuprolideEuropean Urology, 1990
- Phase III studies to compare goserelin (zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinomaUrology, 1989
- Luteinizing hormone-releasing hormone (LHRH) agonists for treatment of advanced prostatic carcinomaUrology, 1989
- How Would You Like to Have an Orchidectomy for Advanced Prostatic Cancer?American Journal of Clinical Oncology, 1988
- Luteinizing hormone-releasing hormone (LH-RH) analogs in treatment of prostatic cancer: Clinical perspectiveUrology, 1986
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984
- Androgen Suppression by a Gonadotropin Releasing Hormone Analogue in Patients with Metastatic Carcinoma of the ProstateJournal of Urology, 1984
- STUDIES ON PROSTATIC CANCERArchives of Surgery, 1941